1-Hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid

Catalog No. :
ACHCXA074
CAS No. :
1347750-85-9
Molecular Formula :
C15H30O9
Molecular Weight :
354.40

IUPAC Name:1-hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid

1-Hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$79.00Login to see priceIn stockInquiry
5g95%$259.00Login to see priceIn stockInquiry
10g95%$472.00Login to see priceIn stockInquiry
25g95%$1121.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid
IUPAC Name1-hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid
MDL No.MFCD22574804
Molecular FormulaC15H30O9
Molecular Weight354.40
SMILESOCCOCCOCCOCCOCCOCCOCCC(O)=O
InChI KeyLGLHJMFNIHYJBM-UHFFFAOYSA-N
SynonymOH-PEG6-COOH;α-hydroxy-ω-propionic acid hexaethylene glycol;Hydroxy-PEG6-acid;HO-PEG7-acid;Hydroxy-PEG6-propionic acid;HO-PEG6-CH2CH2COOH;Propanoic acid, 3-[(17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl)oxy]-;3-[(17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl)oxy]-propanoic acid
CAS No.1347750-85-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHCXA074 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMXUD874 route compound structure diagram
    ACMXUD874361189-64-2 In Stock
  2. Then
  3. ACHCXA074 route product structure diagram
    ACHCXA0741347750-85-9 In Stock
Inquiry

2. ACHCXA074 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHCXA074 route product structure diagram
    ACHCXA0741347750-85-9 In Stock
Inquiry

Comments (0)